Core Insights - Shiseido made its global debut of the innovative medical beauty philosophy "Shiseido Medical Beauty Cycle" at the China International Import Expo, showcasing a new medical beauty brand RQ PYOLOGY developed by a Chinese team [1][3] Group 1: Medical Beauty Philosophy - The "Shiseido Medical Beauty Cycle" aims to create a collaborative system between medical beauty and home care, forming a complete and sustainable skincare lifecycle that includes precise measurement, professional care, and home maintenance [3] - The system leverages over 500 active ingredients from Shiseido's research library to enhance the synergy between medical beauty and daily skincare, ensuring exceptional efficacy [3] Group 2: Local Collaborations and Innovations - Shiseido highlighted its clinical validation of the "Medical and Cosmetic Combined Use" solution in collaboration with Shanghai Ninth People's Hospital, as well as the development of recombinant collagen medical devices with Chuangjian Medical [4] - The debut of the RQ PYOLOGY brand represents the practical application of the "Shiseido Medical Beauty Cycle" and exemplifies Shiseido's commitment to localized co-creation strategies [4] Group 3: RQ PYOLOGY Brand and Technology - The RQ PYOLOGY brand introduced its core technology, "Triple Recombinant Collagen Composite Technology," which precisely repairs all skin layers by balancing types I, III, and XVII collagen [5] - RQ PYOLOGY also established a unique "Skin Rhythm Evaluation System" that quantifies skin quality across six dimensions, providing consumers with detailed skin condition reports [5] - The brand offers a comprehensive medical beauty skincare plan covering the entire cycle from pre-surgery stabilization to post-surgery recovery and home care, supported by a product system of "Class II medical devices + original imported cosmetics" [5] Group 4: Future Outlook - Shiseido's CEO for China and Travel Retail emphasized that the Chinese market is a frontier for the application of innovative technologies, and the company will continue to expand the boundaries of beauty while promoting a more scientific and sustainable future for the skincare industry in China [5]

Core Insights - The beauty and personal care sector has emerged as a key driver of sales during the "618" shopping festival, with significant year-on-year growth in sales for various beauty brands [1][2] - The medical aesthetics industry is experiencing rapid technological advancements and product innovations, leading to a diversified development landscape [1] - Domestic beauty brands are gaining competitive advantages through high cost-performance ratios and refined operations, indicating strong future growth potential in the beauty and personal care segment [1] E-commerce Performance - During the "618" promotion, beauty care products showed robust growth, with platforms like Tmall and JD.com reporting significant sales increases [1] - JD.com's data revealed that on May 20, sales of perfume and makeup sets surged nearly 300% year-on-year, with other categories like lipsticks and serums also seeing over 100% growth [1] - Tmall's data indicated that several beauty brands, including Proya and Lancôme, achieved over 100 million yuan in sales within minutes of the promotion's start [2] Product Innovation and Development - Companies are intensifying their focus on the beauty care sector, leveraging technological breakthroughs to gain competitive advantages [2][3] - Lepu Medical has expanded into ophthalmology and dermatology, recently receiving regulatory approval for a new facial filler product [3] - Proya launched a medical-grade collagen patch, while Jinbo Bio has introduced a new type of injectable collagen gel, marking significant advancements in their respective fields [3] Financial Performance and Market Trends - The beauty and personal care industry is witnessing a positive trend in net profit growth among several companies, with Jinbo Bio reporting a 62.51% increase in revenue and a 66.25% rise in net profit for Q1 2025 [4] - The demand for beauty care products is highly sensitive to new consumer trends, positioning them as a primary growth area in the market [4] - The high added value and profit margins of beauty care products, combined with the rapid innovation cycle, are driving structural growth opportunities for brands in the sector [4]

Core Viewpoint - The domestic cosmetics and medical beauty industry is experiencing rapid growth driven by policy incentives, recovering consumption, and trade friction, with domestic brands gaining significant market share and attention [1][20]. Group 1: Market Performance - The Wind Cosmetics Index has risen over 20% since April 7, with Proya's stock increasing by more than 20% in the same period, and Marubi's stock rising nearly 70% over three months since February [1]. - During the 618 pre-sale event, over 13,000 brands saw doubled sales, with 43 brands quickly surpassing 100 million yuan in sales, marking a 50% increase in the number of brands in the "billion club" compared to last year [4]. - The beauty industry saw a 6.6% year-on-year increase in total sales during the 2024 618 event, with skincare sales reaching 38.876 billion yuan (up 5.18%) and fragrance and makeup sales at 11.073 billion yuan (up 12.08%) [5]. Group 2: Brand Performance - Domestic brands are outperforming international brands, with Proya's sales on Tmall increasing by 70% year-on-year and Douyin's GMV rising by 110%, significantly exceeding platform growth rates [6]. - International brands like L'Oréal and Estée Lauder have seen a decline in sales, with Lancôme experiencing only slight growth [7]. - The market share of domestic beauty brands reached 50.4% for the first time, surpassing international brands and establishing them as the main force in China's cosmetics market [20]. Group 3: Consumer Trends - There is a growing recognition of domestic brands among consumers, particularly younger consumers who prioritize cost-effectiveness and cultural identity in products, laying a foundation for long-term growth [21]. - The 2024 China Beauty Industry White Paper indicates that over 60% of consumers are willing to purchase domestic beauty products with innovative technology or ingredients [35]. Group 4: Financial Performance - Proya's revenue for 2024 exceeded 10.778 billion yuan, with a net profit growth of 30%, leading to a stock price surge [22]. - Marubi reported a revenue of 2.970 billion yuan for 2024, a year-on-year increase of 33.44%, with a net profit of 342 million yuan, also showing strong growth [25]. - Yatsen Holding, the parent company of Perfect Diary, reported a revenue of 3.393 billion yuan for 2024, a slight decline of 0.63%, and a net loss of 708 million yuan, indicating ongoing financial struggles [30]. Group 5: Competitive Landscape - The beauty industry is becoming increasingly saturated, with brands competing fiercely for market share, leading to a more challenging operating environment for brand owners [18]. - Brands with strong R&D capabilities and comprehensive channel operations are likely to survive, while those lacking core competitiveness may face elimination [39].

Core Viewpoint - The beauty and personal care sector is experiencing a strong resurgence, with stocks such as Lafang Home and others seeing significant gains due to multiple driving factors including policy benefits, consumer recovery, and ongoing trade tensions [1] Group 1: Stock Performance - Lafang Home has reached its daily limit increase [1] - Other companies such as Shuiyang Co., Bavi Co., Proya, Runben, Jieya, Beitaini, Zhongshun Jierou, and Fulejia have also seen stock price increases [1] Group 2: Industry Drivers - The cosmetics and medical beauty industry is showing a stable and positive development trend [1] - Factors contributing to this trend include the continuous release of policy dividends, recovery in consumer spending, and the escalation of trade frictions [1]